Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Pentoxifylline Dampens Hyperinflammatory Responses in Preter
2026-07-08
Schüller et al. deliver the first detailed in vitro characterization of pentoxifylline’s (PTX) immunomodulatory effects on LPS-stimulated monocytes from preterm infants. Their findings highlight age-dependent suppression of key surface activation markers, pro-inflammatory cytokines, and TLR4 signaling, clarifying PTX's potential as adjunct therapy in neonatal sepsis.
-
Pentoxifylline: Phosphodiesterase Inhibitor in Inflammation
2026-07-08
Pentoxifylline is a non-specific phosphodiesterase inhibitor that elevates intracellular cAMP, suppresses pro-inflammatory cytokines, and downregulates monocyte ICAM-1 expression. These properties underpin its utility as an anti-inflammatory and immunomodulatory agent in both in vitro and in vivo research. Application parameters and mechanistic benchmarks are well established for translational models.
-
Balsalazide Disodium: Targeted Prodrug Strategy for Ulcerati
2026-07-07
This review examines the innovation and clinical significance of balsalazide disodium as a colon-targeted prodrug for ulcerative colitis. The reference study demonstrates improved remission induction, favorable safety, and rapid onset relative to conventional 5-ASA agents, with implications for both mechanistic inflammation research and translational applications.
-
Isolation and Characterization of Baicalin Methyl Ester from
2026-07-07
The reference study isolated and structurally characterized two new flavone 2'-glucosides and seven known phenolics, including baicalin methyl ester, from the roots of Scutellaria baicalensis. These findings provide a foundational chemical map for subsequent mechanistic research and practical exploration of baicalin derivatives in models of intestinal barrier dysfunction and inflammation.
-
Pomalidomide (CC-4047): Protocols and Innovations for Myelom
2026-07-06
Pomalidomide (CC-4047) is redefining hematological malignancy research by enabling precise modulation of the tumor microenvironment and robust inhibition of pro-tumor cytokines. This article provides actionable protocol recommendations, advanced troubleshooting strategies, and insight into leveraging mutational landscape data for optimized experimental design.
-
Mitochondrial Apoptosis in Ovarian Cancer-Related Muscle Atr
2026-07-06
This study reveals that inhibiting mitochondrial-linked apoptosis via the antioxidant SkQ1 does not prevent skeletal muscle atrophy in a metastatic ovarian cancer mouse model. The findings decouple mitochondrial ROS-driven apoptotic signaling from muscle wasting in type II B fibers, challenging prior assumptions about the causal role of apoptosis and necroptosis in cancer cachexia.
-
Z-IETD-FMK: Deep Dive into Caspase-8 Inhibition for Immune M
2026-07-05
Explore how Z-IETD-FMK, a specific caspase-8 inhibitor, advances immune cell activation research and apoptosis assays. This article uniquely connects mechanistic insights to practical assay design, offering an evidence-based guide for immunology and cell biology laboratories.
-
Procainamide Hydrochloride in Cardiac and Oncology Research
2026-07-04
Procainamide Hydrochloride bridges cardiac electrophysiology and oncology, offering unique workflow advantages as both a sodium channel blocker and DNMT1 inhibitor. This guide translates the latest reference breakthroughs—like its chemoprotective synergy with cisplatin—into actionable protocols and troubleshooting strategies for advanced preclinical research.
-
Applied Workflows with PP 1: Src Family Tyrosine Kinase Inhi
2026-07-03
PP 1 empowers researchers with nanomolar precision in dissecting Src family kinase-driven pathways, enabling reliable modeling of cancer progression and immune modulation. This article delivers actionable protocol enhancements, troubleshooting insights, and cross-study comparisons that elevate experimental design and interpretability.
-
Procainamide Hydrochloride in Cardiac and Oncology Research
2026-07-03
Procainamide Hydrochloride is redefining cardiac electrophysiology and oncology workflows through its dual-action as a sodium channel blocker and epigenetic modulator. Discover optimized protocols, troubleshooting strategies, and new combinatorial assay designs that maximize data reproducibility and translational impact.
-
BX795 as a PDK1 Inhibitor: Protocols for Cancer & Immunity
2026-07-02
BX795 enables precise and reproducible interrogation of the PI3K/Akt/mTOR axis and innate immune signaling in both cancer and immunology workflows. This guide details experimental protocols, troubleshooting strategies, and innovative use-cases leveraging APExBIO’s BX795 for robust kinase pathway analysis.
-
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine:
2026-07-02
Unlock robust immune rejection modulation with 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, a selective α2-adrenergic receptor agonist optimized for hydrogel-based delivery and post-surgery osteosarcoma recurrence research. This guide details experimental workflows, troubleshooting nuances, and actionable insights from the latest research on α2-AR signaling.
-
Rapamycin (Sirolimus): Protocol Optimization & Applied Use-C
2026-07-01
Rapamycin (Sirolimus) is a gold-standard mTOR inhibitor with unparalleled specificity, enabling mechanistic clarity in cancer, immunology, and disease modeling studies. This article delivers actionable protocols, troubleshooting strategies, and highlights a novel workflow from recent autophagy research to maximize reproducibility and translational value.
-
Balsalazide Disodium Dihydrate: Colonic Delivery and Researc
2026-07-01
Explore the unique colonic activation and translational research advantages of Balsalazide Disodium Dihydrate, a prodrug of 5-aminosalicylic acid. This article uncovers mechanistic insights and protocol strategies that extend beyond standard inflammation research.
-
Affinity-Purified Goat Anti-Mouse IgG (H+L): Workflow & Opti
2026-06-30
Unlock robust signal amplification and reproducible detection in immunoassays using the Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated antibody. From setup to troubleshooting, this guide delivers actionable protocols and data-driven insights for Western blot, ELISA, and IHC—empowering researchers to optimize sensitivity and reliability in mouse antibody-based experiments.